Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06425055
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-05-14
Brief Title:
Vonafexor ALPort Syndrome Efficacy Safety TRIAl-1 ALPESTRIA-1
Sponsor:
Enyo Pharma
Organization:
Enyo Pharma
Organization Data
Organization:
Enyo Pharma
Class:
INDUSTRY
Study ID:
EYP001-208
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Enyo Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None